What is SpaceOAR Hydrogel?
Find Out How SpaceOAR
SpaceOAR Clinical Studies
Frequently Asked Questions
5/31/2017 – Augmenix has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its SpaceOAR® System in Japan.
5/15/2017 – The final results of the SpaceOAR System phase III trial including a three-year post treatment follow-up were presented by Brian Davis M.D., Ph.D. Professor of Radiation Oncology Rochester, Minnesota USA. In addition, Razvan Galalae M.D. Ph.D Associate Professor, Christian Albrechts Univeristy of Kiel and Head of the Department of Radiotherapy, Evangelical Clinics Gelsenkirchen, Germany presented on the use of SpaceOAR Hydrogel in high precision prostate radiotherapy. View the full symposium here.
2/17/2017 – Evaluation of sexual function on a randomized trial of a prostate /rectal spacer” published as an abstract at the 2017 ASCO GU meeting demonstrated that the use of SpaceOAR hydrogel prior to prostate cancer radiation therapy significantly decreased dose to the penile bulb which may be associated with the ability to maintain sexual function and potency through 3 years follow up. – Read the Press Release, the Abstract or the Poster.
Dr. Paul Nguyen – Radiation Oncologist, Brigham and Women’s Hospital, Boston, MA
1/11/2017 – The Prostate Health Education Network: Prostate Health Education and Awareness
Watch it here on 1/11/2017…
12/24/2016 – Daniel A. Hamstra, MD, PhD, Int J Radiat Oncol Biol Phys. Dec 2015, Article in Press. – Read more…
Certain forms of prostate cancer are especially aggressive, while others will be almost entirely resistant to many of the known or common forms of treatment, and these are generally the most dangerous of all.
Telling a child that a loved one has cancer is never easy. Consider this information as a guide to help make the process smoother.
As the caregiver, family member or friend of someone living with prostate cancer, there are a few pieces of advice to keep in mind.